Integra LifeSciences Holdings Corporation
NASDAQIntegra LifeSciences just delivered the kind of earnings beat that reminds shorts why crowded positions are dangerous — the stock jumped 24% in a single session, leaving 16% of its free float still short and the lending market suddenly a lot less comfortable. The catalyst was a Q1 print that ran ahead of depressed expectations. The company posted adjusted EPS above the low bar the…
Snapshot as of 6 May 2026
Integra LifeSciences just delivered the kind of earnings beat that reminds shorts why crowded positions are dangerous — the stock jumped 24% in a single session, leaving 16% of its free float still short and the…
Integra LifeSciences heads into its Q1 2026 earnings call — confirmed for May 5 — with short sellers adding aggressively and the stock at a multi-year low of $10.08. Short interest is the dominant story here, and it is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IART — free to start on ORTEX.
Sign up for free →Open IART on ORTEX